Assessing the short- and long-term prognosis of patients with cirrhosis and acute variceal bleeding;Valoración del pronóstico a corto y largo plazo de pacientes con cirrosis y hemorragia digestiva por hipertensión portal

Revista Espanola de Enfermedades Digestivas

Volumn 101, Issue 4, 2009, Pages 236-248

  Sempere, Laura ^a   Palazon J M ^a   Sanchez Paya J ^a   Pascual, S ^a   De Madaria, E ^a   Poveda, M J ^a   Carnicer, F ^a   Zapater, P ^a   Perez Mateo M ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Child Turcotte Pugh score; MELD score; Portal hypertension; Prognosis; Variceal bleeding

Indexed keywords

ADULT; AGED; ARTICLE; CHILD TURCOTTE PUGH SCORE; CLINICAL ASSESSMENT; COHORT ANALYSIS; DEATH; ENDOSCOPY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PROGNOSIS; SCORING SYSTEM; SEX; SURVIVAL; SURVIVAL TIME; TEACHING HOSPITAL;

ACUTE DISEASE; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 70349957999     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800-809
2. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003; 98: 653-659 (Pubitemid 36348540)
3. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40: 652-659 (Pubitemid 39265587)
4. D'Amico G, De Franchis R and Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38: 599-612.
5. Bosch J, García-Pagan JC. Prevention of variceal rebleeding. Lancet 2003; 361: 2244-2245
6. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649
7. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing trans-jugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871
8. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96 (Pubitemid 36055342)
9. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology 2000; 35: 1282-1284 (Pubitemid 34454029)
10. Lee JY, Lee JH, Kim SJ, Choi DR, Kim KH, Kim YB, et al. Comparison of predictive factors related to the mortality and rebleeding caused by variceal bleeding: Child-Pugh score, MELD score, and Rockall score. Taehan Kan Hakhoe Chi 2002; 8: 458-464
11. Amitrano L, Guardascione MA, Bennato R, Manguso F, Balzano A. MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices. J Hepatol 2005; 42: 820-825 (Pubitemid 40693198)
12. Bosh X, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: s5-s16. (Pubitemid 39423365)
13. Mohsen AH, Easterbrook PJ, Taylor C, Portmann B, Kulasegaram R, Murad S, et al. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut 2003; 52: 1035-1040 (Pubitemid 36765298)
14. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2002; 37: 874.
15. de Franchis R. Developing consensus in portal hypertension. J Hepatol 1996; 25: 390-394
16. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846-852
17. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167-176
18. Llach J, Gines P, Arroyo V, Rimola A, Tito L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988; 94: 482-487 (Pubitemid 18054789)
19. Fernández-Esparrach G, Sánchez-Fueyo A, Gines P, Uriz J, Quinto L, Ventura PJ, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001; 34: 46-52. (Pubitemid 32102551)
20. Arroyo V, Rodes J, Gutiérrez-Lizarraga MA, Revert L. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis 1976; 21: 249-256
21. Arroyo V, Bosch J, Gaya-Beltran J, Kravetz D, Estrada L, Rivera F, et al. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. Ann Intern Med 1981; 94: 198-201. (Pubitemid 11188505)
22. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217-231 (Pubitemid 41772537)
23. Yeo W, Sung JY, Ward SC, Chung SC, Lee WY, Li AK, et al. A prospective study of upper gastrointestinal hemorrhage in patients with hepatocellular carcinoma. Dig Dis Sci 1995; 40: 2516-2521 (Pubitemid 26032339)
24. Sung JJ, Yeo W, Suen R, Lee YT, Chung SC, Chan FK, et al. Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulphate. Gastrointest Endosc 1998; 47: 235-239 (Pubitemid 28155344)
25. Merion RM, Wolfe RA, Dykstra DM, Leichtman AB, Gillespie B, Held PJ. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 2003; 9: 12-18 (Pubitemid 36104909)
26. Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, et al. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J Hepatol 2005; 42: 826-832
27. Prieto M, Clemente G, Casafont F, Cuende N, Cuervas-Mons V, Figueras J, et al. Consensus document on indications for liver transplantation 2002. Gastroenterol Hepatol 2003; 26: 355-375